vs

Side-by-side financial comparison of RxSight, Inc. (RXST) and TSS, Inc. (TSSI). Click either name above to swap in a different company.

TSS, Inc. is the larger business by last-quarter revenue ($60.9M vs $32.6M, roughly 1.9× RxSight, Inc.). TSS, Inc. runs the higher net margin — 20.0% vs -28.1%, a 48.0% gap on every dollar of revenue. On growth, TSS, Inc. posted the faster year-over-year revenue change (21.8% vs -18.9%). TSS, Inc. produced more free cash flow last quarter ($15.8M vs $-2.3M). Over the past eight quarters, TSS, Inc.'s revenue compounded faster (95.8% CAGR vs 5.1%).

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

RXST vs TSSI — Head-to-Head

Bigger by revenue
TSSI
TSSI
1.9× larger
TSSI
$60.9M
$32.6M
RXST
Growing faster (revenue YoY)
TSSI
TSSI
+40.7% gap
TSSI
21.8%
-18.9%
RXST
Higher net margin
TSSI
TSSI
48.0% more per $
TSSI
20.0%
-28.1%
RXST
More free cash flow
TSSI
TSSI
$18.0M more FCF
TSSI
$15.8M
$-2.3M
RXST
Faster 2-yr revenue CAGR
TSSI
TSSI
Annualised
TSSI
95.8%
5.1%
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RXST
RXST
TSSI
TSSI
Revenue
$32.6M
$60.9M
Net Profit
$-9.2M
$12.2M
Gross Margin
77.5%
17.6%
Operating Margin
-34.8%
1.5%
Net Margin
-28.1%
20.0%
Revenue YoY
-18.9%
21.8%
Net Profit YoY
-54.1%
535.7%
EPS (diluted)
$-0.22
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RXST
RXST
TSSI
TSSI
Q4 25
$32.6M
$60.9M
Q3 25
$30.3M
$41.9M
Q2 25
$33.6M
$44.0M
Q1 25
$37.9M
$99.0M
Q4 24
$40.2M
$50.0M
Q3 24
$35.3M
$70.1M
Q2 24
$34.9M
$12.2M
Q1 24
$29.5M
$15.9M
Net Profit
RXST
RXST
TSSI
TSSI
Q4 25
$-9.2M
$12.2M
Q3 25
$-9.8M
$-1.5M
Q2 25
$-11.8M
$1.5M
Q1 25
$-8.2M
$3.0M
Q4 24
$-5.9M
$1.9M
Q3 24
$-6.3M
$2.6M
Q2 24
$-6.1M
$1.4M
Q1 24
$-9.1M
$15.0K
Gross Margin
RXST
RXST
TSSI
TSSI
Q4 25
77.5%
17.6%
Q3 25
79.9%
11.1%
Q2 25
74.9%
17.8%
Q1 25
74.8%
9.3%
Q4 24
71.6%
14.4%
Q3 24
71.4%
11.3%
Q2 24
69.5%
37.3%
Q1 24
70.1%
17.1%
Operating Margin
RXST
RXST
TSSI
TSSI
Q4 25
-34.8%
1.5%
Q3 25
-40.1%
-2.2%
Q2 25
-41.6%
5.1%
Q1 25
-28.2%
4.2%
Q4 24
-21.5%
0.0%
Q3 24
-26.1%
5.4%
Q2 24
-23.9%
14.0%
Q1 24
-36.2%
1.6%
Net Margin
RXST
RXST
TSSI
TSSI
Q4 25
-28.1%
20.0%
Q3 25
-32.4%
-3.6%
Q2 25
-35.0%
3.4%
Q1 25
-21.6%
3.0%
Q4 24
-14.8%
3.8%
Q3 24
-17.9%
3.8%
Q2 24
-17.4%
11.5%
Q1 24
-30.8%
0.1%
EPS (diluted)
RXST
RXST
TSSI
TSSI
Q4 25
$-0.22
$0.44
Q3 25
$-0.24
$-0.06
Q2 25
$-0.29
$0.06
Q1 25
$-0.20
$0.12
Q4 24
$-0.14
$0.08
Q3 24
$-0.16
$0.10
Q2 24
$-0.16
$0.06
Q1 24
$-0.25
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RXST
RXST
TSSI
TSSI
Cash + ST InvestmentsLiquidity on hand
$228.1M
$85.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.7M
$76.6M
Total Assets
$311.8M
$184.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RXST
RXST
TSSI
TSSI
Q4 25
$228.1M
$85.5M
Q3 25
$227.5M
$70.7M
Q2 25
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
$23.2M
Q3 24
$237.1M
$46.4M
Q2 24
$233.3M
$8.3M
Q1 24
$125.4M
$14.4M
Stockholders' Equity
RXST
RXST
TSSI
TSSI
Q4 25
$275.7M
$76.6M
Q3 25
$276.0M
$63.4M
Q2 25
$278.0M
$9.5M
Q1 25
$279.3M
$9.4M
Q4 24
$281.2M
$7.1M
Q3 24
$277.3M
$7.7M
Q2 24
$275.2M
$5.2M
Q1 24
$163.9M
$3.7M
Total Assets
RXST
RXST
TSSI
TSSI
Q4 25
$311.8M
$184.9M
Q3 25
$308.5M
$165.4M
Q2 25
$309.0M
$139.5M
Q1 25
$313.0M
$113.5M
Q4 24
$318.6M
$96.6M
Q3 24
$310.5M
$67.3M
Q2 24
$305.5M
$28.9M
Q1 24
$183.2M
$26.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RXST
RXST
TSSI
TSSI
Operating Cash FlowLast quarter
$-1.1M
$16.3M
Free Cash FlowOCF − Capex
$-2.3M
$15.8M
FCF MarginFCF / Revenue
-6.9%
25.9%
Capex IntensityCapex / Revenue
3.5%
0.9%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$-19.3M
$2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RXST
RXST
TSSI
TSSI
Q4 25
$-1.1M
$16.3M
Q3 25
$-1.2M
$-18.4M
Q2 25
$-4.4M
$16.3M
Q1 25
$-8.8M
$20.6M
Q4 24
$-4.3M
$-21.6M
Q3 24
$650.0K
$38.6M
Q2 24
$-4.0M
$-4.3M
Q1 24
$-9.3M
$2.6M
Free Cash Flow
RXST
RXST
TSSI
TSSI
Q4 25
$-2.3M
$15.8M
Q3 25
$-1.8M
$-24.9M
Q2 25
$-5.9M
$5.4M
Q1 25
$-9.4M
$5.8M
Q4 24
$-5.1M
$-28.4M
Q3 24
$-453.0K
$38.6M
Q2 24
$-5.5M
$-6.0M
Q1 24
$-11.3M
$2.6M
FCF Margin
RXST
RXST
TSSI
TSSI
Q4 25
-6.9%
25.9%
Q3 25
-5.8%
-59.3%
Q2 25
-17.6%
12.3%
Q1 25
-24.8%
5.8%
Q4 24
-12.7%
-56.7%
Q3 24
-1.3%
55.1%
Q2 24
-15.9%
-49.4%
Q1 24
-38.2%
16.4%
Capex Intensity
RXST
RXST
TSSI
TSSI
Q4 25
3.5%
0.9%
Q3 25
1.9%
15.3%
Q2 25
4.6%
24.8%
Q1 25
1.5%
15.0%
Q4 24
2.1%
13.4%
Q3 24
3.1%
0.1%
Q2 24
4.4%
13.8%
Q1 24
6.7%
0.2%
Cash Conversion
RXST
RXST
TSSI
TSSI
Q4 25
1.34×
Q3 25
Q2 25
11.02×
Q1 25
6.93×
Q4 24
-11.32×
Q3 24
14.60×
Q2 24
-3.09×
Q1 24
176.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

TSSI
TSSI

Procurement Revenues Segment$43.2M71%
System Integration Services Segment$14.2M23%
Facilities Segment$3.5M6%

Related Comparisons